DK1069893T3 - Anvendelse af dexmedetomidin til sedering på en intensivafdeling - Google Patents

Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Info

Publication number
DK1069893T3
DK1069893T3 DK99913332T DK99913332T DK1069893T3 DK 1069893 T3 DK1069893 T3 DK 1069893T3 DK 99913332 T DK99913332 T DK 99913332T DK 99913332 T DK99913332 T DK 99913332T DK 1069893 T3 DK1069893 T3 DK 1069893T3
Authority
DK
Denmark
Prior art keywords
dexmedetomidine
sedation
intensive care
care unit
intensive
Prior art date
Application number
DK99913332T
Other languages
Danish (da)
English (en)
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corp
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1069893(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp, Hospira Inc filed Critical Orion Corp
Application granted granted Critical
Publication of DK1069893T3 publication Critical patent/DK1069893T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99913332T 1998-04-01 1999-03-31 Anvendelse af dexmedetomidin til sedering på en intensivafdeling DK1069893T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (1)

Publication Number Publication Date
DK1069893T3 true DK1069893T3 (da) 2007-03-19

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913332T DK1069893T3 (da) 1998-04-01 1999-03-31 Anvendelse af dexmedetomidin til sedering på en intensivafdeling

Country Status (27)

Country Link
EP (1) EP1069893B1 (de)
JP (1) JP4606581B2 (de)
KR (1) KR20010034728A (de)
CN (1) CN1168441C (de)
AR (1) AR015744A1 (de)
AT (1) ATE347359T1 (de)
AU (1) AU754484B2 (de)
BG (1) BG64540B1 (de)
BR (1) BR9909872A (de)
CA (1) CA2326339C (de)
CZ (1) CZ301013B6 (de)
DE (1) DE69934305T2 (de)
DK (1) DK1069893T3 (de)
EA (1) EA005524B1 (de)
ES (1) ES2278441T3 (de)
GB (1) GB2352972B (de)
HU (1) HU229162B1 (de)
IL (1) IL138416A (de)
NO (1) NO329194B1 (de)
NZ (1) NZ507203A (de)
PL (1) PL192517B1 (de)
PT (1) PT1069893E (de)
SI (1) SI1069893T1 (de)
SK (1) SK286160B6 (de)
TR (1) TR200002837T2 (de)
TW (1) TW552136B (de)
WO (1) WO1999049854A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388979C (en) 1999-10-29 2010-09-14 Orion Corporation Treatment or prevention of hypotension and shock with use of an imidazole derivative
PL373850A1 (en) * 2002-04-08 2005-09-19 Guilford Pharmaceuticals, Inc. Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
WO2008036858A2 (en) 2006-09-20 2008-03-27 The Board Of Regents Of The University Of Texas System Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
CN107661293A (zh) 2008-01-22 2018-02-06 得克萨斯大学体系董事会 用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
CN106511273A (zh) * 2009-05-15 2017-03-22 瑞克欧制药有限公司 舌下右美托咪定组合物及其使用方法
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013090278A2 (en) 2011-12-11 2013-06-20 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
AU2013333787B2 (en) * 2012-10-15 2017-06-08 Orion Corporation A veterinary method of alleviating noise aversion
JP6621407B2 (ja) 2013-07-24 2019-12-18 アイ − テック エービー 表面の海洋生物付着に対する阻害剤としてのエナンチオマーレボメデトミジンの使用
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
KR101831290B1 (ko) * 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
KR101827980B1 (ko) * 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
AU754484B2 (en) 2002-11-14
EP1069893B1 (de) 2006-12-06
TW552136B (en) 2003-09-11
ATE347359T1 (de) 2006-12-15
SI1069893T1 (sl) 2007-04-30
IL138416A (en) 2005-07-25
CZ20003484A3 (cs) 2002-01-16
GB2352972A (en) 2001-02-14
NZ507203A (en) 2003-03-28
EP1069893A2 (de) 2001-01-24
TR200002837T2 (tr) 2001-01-22
NO20004931D0 (no) 2000-09-29
DE69934305T2 (de) 2007-07-12
HU229162B1 (hu) 2013-09-30
GB2352972B (en) 2003-05-21
KR20010034728A (ko) 2001-04-25
JP4606581B2 (ja) 2011-01-05
BR9909872A (pt) 2007-11-20
BG104797A (en) 2001-07-31
DE69934305D1 (de) 2007-01-18
BG64540B1 (bg) 2005-07-29
IL138416A0 (en) 2001-10-31
JP2002509880A (ja) 2002-04-02
ES2278441T3 (es) 2007-08-01
SK286160B6 (sk) 2008-04-07
CA2326339C (en) 2008-12-23
SK14362000A3 (sk) 2002-03-05
AU3149499A (en) 1999-10-18
GB0024932D0 (en) 2000-11-29
EA200001010A1 (ru) 2001-02-26
CZ301013B6 (cs) 2009-10-14
WO1999049854A2 (en) 1999-10-07
HUP0101498A1 (hu) 2002-03-28
CA2326339A1 (en) 1999-10-07
AR015744A1 (es) 2001-05-16
CN1168441C (zh) 2004-09-29
CN1295473A (zh) 2001-05-16
PL343553A1 (en) 2001-08-27
NO20004931L (no) 2000-09-29
HUP0101498A3 (en) 2002-06-28
PL192517B1 (pl) 2006-10-31
NO329194B1 (no) 2010-09-13
EA005524B1 (ru) 2005-04-28
WO1999049854A3 (en) 1999-11-18
PT1069893E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
DK1069893T3 (da) Anvendelse af dexmedetomidin til sedering på en intensivafdeling
NO20005215L (no) Dihydropyrimidiner
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
ID27768A (id) Komposisi-komposisi perawatan rambut
ID26776A (id) Komposisi-komposisi perawatan rambut
DK0965343T3 (da) Ziprasidonformuleringer
DE60016672D1 (de) Körpersreinigungsfolie
FR2824267B1 (fr) Composition cosmetique filmogene
DE69900634T2 (de) Shampoozusammensetzungen
DE60321791D1 (de) Dynamisches routen in netzwerken
DE59902843D1 (de) Brauseformulierungen
DE69804342T2 (de) Körperpflegezusammensetzungen
DE69805443D1 (de) Sachet-formulierungen
NO20043418L (no) Stabiliserte adenovirusformuleringer
FR2788058B1 (fr) Compositions cosmetiques amincissantes
AR028087A1 (es) Composiciones cosmeticas
DE50101916D1 (de) Flüssige formulierungen
DE69902473D1 (de) Kosmetikzusammensetzung
DK1498124T3 (da) Anvendelse af inhibitorer i renin-angiotensinsystemet
DE50110553D1 (de) Verwendung herbizider Mittel
FR2781231B1 (fr) Compositions cosmetiques amincissantes
ID30226A (id) Komposisi penat rambut
DE60111988D1 (de) Kosmetische Zusammensetzung
ID27215A (id) Komposisi perawatan rambut